The New England journal of medicine
-
Randomized Controlled Trial Comparative Study
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin.
Insulin icodec is an investigational once-weekly basal insulin analogue for diabetes management. ⋯ Glycemic control was significantly better with once-weekly insulin icodec than with once-daily insulin glargine U100. (Funded by Novo Nordisk; ONWARDS 1 ClinicalTrials.gov number, NCT04460885.).